Premium
Pharmacological evidence that α 1 ‐ and α 2 ‐adrenoceptors mediate vasoconstriction of carotid arteriovenous anastomoses in anaesthetized pigs
Author(s) -
Willems Edwin W,
Trion Marjo,
De Vries Peter,
Heiligers Jan P C,
Villalón Carlos M,
Saxena Pramod R
Publication year - 1999
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0702655
Subject(s) - vasoconstriction , arteriovenous anastomosis , triptans , prazosin , phenylephrine , medicine , rauwolscine , vasodilation , anesthesia , dihydroergotamine , agonist , pharmacology , migraine , antagonist , receptor , anastomosis , surgery , blood pressure
Vasoconstriction of carotid arteriovenous anastomoses may be involved in the therapeutic action of acutely acting antimigraine agents, including the triptans and ergot alkaloids. While 5‐HT 1B/1D receptors mediate the effect of triptans, ergotamine and dihydroergotamine also interact with α‐adrenoceptors. In the present study, we investigated the potential role of α 1 ‐ and α 2 ‐adrenoceptors in mediating vasoconstriction of carotid arteriovenous anastomoses in anaesthetized pigs. Ten minute intracarotid infusions of phenylephrine (1, 3 and 10 μg kg −1 min −1 ) or BHT 933 (3, 10 and 30 μg kg −1 min −1 ) produced dose‐dependent decreases in total carotid and arteriovenous anastomotic conductances; no changes were observed in the capillary fraction. The carotid vascular effects of phenylephrine and BHT 933 were selectively abolished by prazosin (100 μg kg −1 , i.v.) and rauwolscine (300 μg kg −1 , i.v.), respectively. The responses to phenylephrine and BHT 933 were not affected by the selective 5‐HT 1B/1D receptor antagonist GR127935 (500 μg kg −1 , i.v.). These results show that both α 1 ‐ and α 2 ‐adrenoceptors can mediate vasoconstriction of carotid arteriovenous anastomoses in anaesthetized pigs. Since vasoconstrictor activity in this in vivo model is predictive of anti‐migraine activity, an agonist activity at particularly the α 2 ‐adrenoceptor subtypes, in view of their less ubiquitous nature, could provide migraine abortive potential. Thus, the present results may aid further understanding of the mode of action of some current anti‐migraine agents and may eventually be helpful in the development of future treatment in migraine.British Journal of Pharmacology (1999) 127 , 1263–1271; doi: 10.1038/sj.bjp.0702655